GLP-1 synergizes with GIP to promote metabolic homeostasis, prevent hyperglycemia and hypoglycemia, attenuate dyslipidemia, and reduce the risk of cardiovascular disease in patients with T2DM and obesity. The gene discussed is GCG; the disease is type 2 diabetes mellitus.